COMMON STOCK PURCHASE WARRANT BIORESTORATIVE THERAPIES, INC.Common Stock Purchase Warrant • October 29th, 2021 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioRestorative Therapies, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to a Holde
BIORESTORATIVE THERAPIES, INC. and TRANSHARE CORPORATION as Warrant Agent Warrant Agency Agreement Dated as of ___________, 2021 WARRANT AGENCY AGREEMENTWarrant Agency Agreement • October 29th, 2021 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec • New York
WARRANT AGENCY AGREEMENT, dated as of __________, 2021 (“Agreement”), by and between BioRestorative Therapies, Inc., a Delaware corporation (the “Company”), and Transhare Corporation, a _______ corporation (“Transhare” or the “Warrant Agent”).
EXCHANGE AGREEMENTExchange Agreement • October 29th, 2021 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec • New York
EXCHANGE AGREEMENT, dated as of October 22, 2021 (the “Agreement”), by and between BIORESTORATIVE THERAPIES, INC., a Delaware corporation (the “Company”), and CROSSOVER CAPITAL FUND I, LLC (the “Holder”).
